Biogen (BIIB) PT Raised to $360 at Oppenheimer
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $208.87 --0%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $360.00 (from $350.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Lenskart Solutions (LENSKART:IN) PT Raised to INR715 at Axis Capital Limited
- Jack In The Box (JACK) PT Raised to $16 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
